Rifampin Capsule · #17 of 35 active shortages by FDA posting duration
Brand: RIFAMPIN
FDA lists Rifampin Capsule as Active Shortage (Lupin Pharmaceuticals, Inc.).
Availability on file: Limited Availability
Rifampin Capsule: Active Shortage
Limited Availability 12 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Rifampin Capsule
- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Capsule
- Presentation
- Rifampin, Capsule, 300 mg (NDC 68180-659-07)
- Package NDC
- 68180-659-07
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Dec 22, 2021
- Last Updated
- Mar 2, 2026
- Therapeutic Category
- Anti-Infective
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
On allocation
Full Drug Profile
rifampin
Side effects, interactions, warnings & more
Nearby, Other Rifampin Shortage Records
Rifampin Injection
Sanofi-Aventis U.S. LLC
Injection
Rifampin Injection
Mylan Institutional, a Viatris Company
Injection
Rifampin Injection
Fresenius Kabi USA, LLC
Injection
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
Rifampin Capsule
Epic Pharma, LLC
Capsule
FDA reason on file: On allocation. General shortage guidance lives on the tracker hub.